This article is part of our Rising Star Portfolios series.
Math is a funny thing. If an investment loses 50% of its value, you need it to rise 100% just to break even. Unfortunately, we can't avoid this by choosing only investments that go up -- that's simply impossible to do. But we should endeavor to eliminate making dumb mistakes and stack the odds of success in our favor.
Early in my investing career my biggest mistakes came from investing in story stocks. You know the kind: hot product (think Crocs), quickly growing end markets (think FARO Technologies), and many more. In each case, the story behind the stock was so snazzy that I let slide that the numbers and the logic behind the business didn't add up. Painful lessons learned.
My now refined style of investing, having been tried and tested managing an investment fund, seeks to eliminate the likelihood of being blinded by a company's story. By focusing on companies that are unpopular, unattractive, or unknown, I can avoid making those costly mistakes. In cases where the "un" rules, it forces me to think independently, engage in dispassionate analysis, and ask the right (long-term, business-focused) questions. I call it un-vesting, so I've appropriately named my Rising Star Portfolio the Un Portfolio.
Sure, this means I end up looking at some pretty boring businesses. But good companies operate in unsexy industries. Good companies have mishaps and become unpopular. And good companies can be purchased on the cheap.
My first purchases have focused on out-of-favor sectors (health care and defense) where temporary factors are creating bargain opportunities. Shares of medical technology company Medtronic
I urge you to hone your investment process, perhaps becoming an un-vestor yourself. If nothing else, following the Un Port will provide a variety of stock picks that will encourage you to focus on the investment's merits and not its story or the prevailing viewpoint.
Bryan Hinmon does not own shares of any company mentioned. SAIC is a Motley Fool Inside Value recommendation. The Motley Fool owns shares of Medtronic, ManTech, and SAIC. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool has a disclosure policy.
More from The Motley Fool
5 Dividend Aristocrats With the Fastest-Growing Dividends
The best kind of dividend stocks: long track records of dividend hikes -- and huge dividend increases.
3 Best Healthcare Dividend Aristocrat Stocks You Can Buy Right Now
Great dividends. Great track records of dividend hikes. And great businesses, too.
3 Stocks at 52-Week Highs Still Worth Buying
Rio Tinto plc, Take-Two Interactive, and Mazor Robotics just reached 52-week highs. Here's why our team thinks that it's still a great time to buy.